Encora helps people with neurodegenerative movement disorders regain independence and control in their lives.
Encora Therapeutics's investors include Good Growth Capital, MassChallenge, Innospark Ventures, SBXi, MIT delta v.
Encora Therapeutics is headquartered in Boston, United States.
Encora helps people with neurodegenerative movement disorders regain independence and control in their lives.
Encora Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Encora Therapeutics — Funding & Investors." VCBacked, September 20, 2022, https://www.vcbacked.co/company/encora-therapeutics. Accessed October 19, 2026.
VCBacked. (2022). Encora Therapeutics — Funding & Investors. Retrieved October 19, 2026, from https://www.vcbacked.co/company/encora-therapeutics
{{cite web |title=Encora Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/encora-therapeutics |website=VCBacked |access-date=October 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated